Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.53ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.53EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.53EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.528EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.528EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.528ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.528ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.528EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.528EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.528ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.528ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.175EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.175EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.175ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.175ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.175EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.175EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.175ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.175ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.6.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.6.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.6.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.6.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.6.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.6.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.29 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.29 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.29 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.29 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.29 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.29 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.29 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ML.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ML.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ML.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
ML.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
ML.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used